Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-08-22 to 2025-08-25
Current total value of award: $1950.22
Description: 4569191637!TELMISARTAN-HCTZ 80-12.5 MG TB UD 30S